Value in Health Regional Issues
Scope & Guideline
Exploring the Economics of Health, One Region at a Time.
Introduction
Aims and Scopes
- Economic Evaluation of Health Interventions:
The journal publishes studies that assess the cost-effectiveness, cost-utility, and budget impact of various health interventions, helping to inform decisions on resource allocation in healthcare. - Health-Related Quality of Life Research:
A significant focus is on measuring and valuing health-related quality of life (HRQoL) using instruments like EQ-5D and SF-6D, which are crucial for understanding the impact of diseases and treatments on patients' lives. - Regional Health Policy Insights:
The journal emphasizes research that provides context-specific insights into health policies and economic evaluations in low- and middle-income countries, addressing unique regional health challenges. - Patient and Societal Preferences:
Research on patient and societal preferences for health technologies and treatments is highlighted, utilizing methods such as discrete choice experiments to capture the values and trade-offs important to stakeholders. - Impact of Chronic Diseases and Emerging Health Issues:
The journal frequently addresses the economic burden and healthcare utilization associated with chronic diseases, as well as emerging health issues like the COVID-19 pandemic, focusing on their economic implications.
Trending and Emerging
- Post-Pandemic Health Economics:
There is a marked increase in studies examining the economic impact of the COVID-19 pandemic on healthcare systems, resource utilization, and long-term health outcomes, reflecting the need to understand and mitigate the pandemic's effects. - Value-Based Healthcare Models:
Emerging research is increasingly focused on value-based healthcare frameworks, assessing how care delivery models can be optimized to improve patient outcomes while controlling costs. - Digital Health Technologies and Innovations:
There is a rising interest in evaluating the economic implications of digital health technologies and telemedicine, particularly in the context of enhanced access to care and efficiency improvements. - Chronic Disease Management and Economic Burden:
The journal is seeing a trend towards in-depth analyses of chronic disease management strategies, particularly related to their economic burden on healthcare systems and society. - Health Equity and Access to Care:
Emerging themes include the economic evaluation of interventions aimed at improving health equity and access to care for marginalized populations, reflecting a growing awareness of social determinants of health.
Declining or Waning
- Traditional Cost-Effectiveness Analysis:
While still relevant, traditional cost-effectiveness analyses are increasingly supplemented or replaced by more comprehensive evaluations that consider broader societal impacts and patient preferences. - Generalized Economic Burden Studies:
Research that broadly addresses the economic burden of diseases without specific contextual factors or detailed evaluations appears to be declining, as more nuanced and targeted studies gain traction. - Single-Country Focus Studies:
Research focused solely on single-country analyses is decreasing, with a growing preference for comparative studies that evaluate health interventions across multiple countries or regions. - Pharmacoeconomic Education Initiatives:
The emphasis on educational studies related to pharmacoeconomics appears to be waning, as the journal shifts its focus towards more practical applications and outcomes of economic evaluations. - Historical Health Technology Assessments:
There is a noticeable decline in publications that focus on historical evaluations of health technology assessments, as the emphasis shifts toward contemporary challenges and innovative methodologies.
Similar Journals
PHARMACOECONOMICS
Leading the way in pharmacoeconomic evaluations since 1992.PHARMACOECONOMICS, published by ADIS INT LTD, is a prestigious international journal dedicated to disseminating research in the fields of health policy, pharmacology, and public health. With an impressive impact factor and a solid Q1 ranking across its relevant categories, this journal plays a crucial role in shaping policy decisions, optimizing health resources, and enhancing pharmacoeconomic evaluations globally. The journal not only targets researchers and professionals but also serves as an invaluable resource for students striving to understand the economic implications of pharmaceutical care. Operating since 1992 and continuously evolving through 2024, PHARMACOECONOMICS invites contributions that address the complexities of drug expenditure, health outcomes, and public health implications, thereby fostering informed decision-making in healthcare systems. Readers can explore cutting-edge studies and analyses aimed at balancing cost-effectiveness with clinical effectiveness, making this journal a cornerstone for stakeholders invested in the future of health economics.
Expert Review of Pharmacoeconomics & Outcomes Research
Delivering Impactful Insights for Optimal Healthcare SolutionsExpert Review of Pharmacoeconomics & Outcomes Research is a leading journal published by TAYLOR & FRANCIS LTD, focusing on the critical intersection of pharmacoeconomics and healthcare outcomes. Established in 2001, the journal has been a key resource for researchers and professionals in the fields of health policy, medicine, and pharmacology, consistently ranked in the top quartile of these categories for its influential insights. With an ISSN of 1473-7167 and an E-ISSN of 1744-8379, it delivers cutting-edge research that informs healthcare decisions and policy frameworks. The journal's rigorous peer-review process ensures the publication of high-quality, impactful articles that address contemporary challenges and advancements in pharmacoeconomic evaluations. As of 2023, it boasts a commendable ranking of #106 in Health Policy and #124 in Pharmacology, affirming its relevance and contribution to the field. Despite being a subscription-based journal, the strength of its content makes it an invaluable tool for researchers and practitioners aiming to enhance patient outcomes and optimize resource allocation in healthcare systems.
BMJ Open Respiratory Research
Fostering collaboration in the pursuit of respiratory excellence.BMJ Open Respiratory Research is a prestigious open access journal published by the BMJ Publishing Group, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2014, the journal has provided a vital platform for the dissemination of innovative research and clinical findings, boasting an impressive Q1 ranking in its category as of 2023. With a Scopus rank of #35 out of 155 in Pulmonary and Respiratory Medicine, BMJ Open Respiratory Research is recognized for its high-quality content, engaging a global audience of researchers, healthcare professionals, and students. The journal embraces an open access model, ensuring that groundbreaking research is readily available to the community and stakeholders, thereby accelerating knowledge exchange and improving patient care. By focusing on diverse aspects of respiratory health, this journal plays a crucial role in shaping the future of respiratory research and practice.
Applied Health Economics and Health Policy
Bridging economic theory and health policy for a healthier future.Applied Health Economics and Health Policy, published by Springer International Publishing AG, stands as a premier academic journal dedicated to the intersection of economic theory and health policy. With a strong focus on the practical application of economic principles to health issues, this journal addresses crucial topics such as healthcare financing, resource allocation, and economic evaluation of health interventions. Its impressive rankings—in the top quartile for both Health Policy and Medicine, as well as a notable second quartile in Economics—illustrate its significant impact within the fields of health economics and policy research. The journal is aimed at researchers, policymakers, and students who seek to explore innovative solutions to contemporary health challenges. Established in 2002 with ongoing publications through 2024, the journal features open access options that enhance accessibility and engagement with its extensive body of research articles, ensuring that vital insights are available to a global audience.
MEDICAL DECISION MAKING
Connecting researchers, practitioners, and policymakers for optimal health solutions.Medical Decision Making is a premier journal published by SAGE Publications Inc, dedicated to advancing the field of health policy through rigorous research, innovative methodologies, and comprehensive analyses. Since its inception in 1981, it has established itself as a leading platform for disseminating significant findings, and it proudly holds a Q1 ranking in the health policy category, underscoring its commitment to excellence within the academic community. With an impressive Scopus rank of 43 out of 310, the journal ranks in the top 14% of its field, reflecting its influential contributions to medical decision-making processes. Medical Decision Making serves a diverse audience of researchers, practitioners, and policymakers by providing scholarly articles that blend theoretical insights with practical applications, ultimately improving patient care and health outcomes. The journal's dedicated following and its continued relevance through to 2024 position it as an essential resource for anyone vested in the evolution and implementation of effective health policies.
Journal of Health Economics and Outcomes Research
Driving innovation in health services research.Journal of Health Economics and Outcomes Research, published by COLUMBIA DATA ANALYTICS, LLC, serves as a vital resource in the field of health policy and public health, providing researchers, professionals, and students with open access to pioneering studies since its inception in 2013. With its ISSN and E-ISSN both listed as 2327-2236, this journal aims to disseminate high-quality research that evaluates healthcare efficiency and outcomes. Situated in the United States, at 145 Hudson St., Suite 205, New York, NJ 10013, it has made significant strides in its category quartiles within the 2023 rankings, achieving Q2 status in both Health Policy and Public Health, Environmental and Occupational Health. Furthermore, it maintains respectable Scopus rankings, with a percentile of 51st in health policy and 49th in public health. By bridging gaps in health economics and policy discourse, the journal stands as an indispensable platform for advancing knowledge and fostering innovation in health services research.
Journal of Epidemiology and Global Health
Transforming understanding of global health challenges, one article at a time.The Journal of Epidemiology and Global Health (ISSN: 2210-6006; E-ISSN: 2210-6014), published by SpringerNature, stands as a premier open-access platform in the field of epidemiology, dedicated to advancing our understanding of global health challenges since 2011. Based in Switzerland, this journal is recognized for its significant contributions to the discipline, achieving an impressive Q1 ranking in Epidemiology and positioning itself at the 88th percentile within the Scopus Medicine - Epidemiology category. With a goal to disseminate innovative research and foster dialogue among scholars, public health professionals, and students, the journal provides a rich repository of empirical studies, reviews, and theoretical contributions that address pressing epidemiological issues. Its commitment to open access ensures that vital research is freely available to the global community, thereby amplifying its impact and relevance. Researchers seeking to publish and access high-quality, peer-reviewed articles will find the Journal of Epidemiology and Global Health an invaluable resource in navigating the ever-evolving landscape of public health.
Gesundheitsoekonomie und Qualitaetsmanagement
Driving Innovation in Health Policy and Quality AssuranceGesundheitsoekonomie und Qualitaetsmanagement, published by THIEME MEDICAL PUBL INC, serves as a vital resource in the field of health policy, particularly within the context of Germany. Since its inception in 1999, this journal has been committed to advancing the discourse on health economics and quality management, making significant contributions to understanding the complexities of healthcare systems. With an impact factor that reflects its ongoing importance, the journal is categorized in the Q4 quartile for Health Policy as of 2023, indicating its role in serving a niche yet crucial space in medical literature. Although currently not an open access journal, it remains accessible through various academic platforms, making its content available to a diverse audience of researchers, healthcare professionals, and students eager to engage with contemporary issues in health economics. With its publication continuing through 2024, Gesundheitsoekonomie und Qualitaetsmanagement is essential for anyone looking to deepen their understanding of the economic aspects of healthcare and ensure quality management in health services.
Pharmacoeconomics-Open
Unlocking Insights for a Healthier TomorrowPharmacoeconomics-Open, an esteemed journal published by SPRINGER INT PUBL AG, is a vital resource for scholars and practitioners in the fields of health policy and pharmacology. Since its transition to an Open Access platform in 2017, the journal has aimed to democratize access to valuable research, fostering innovation and collaboration globally. With notable rankings in the 2023 Scopus indices—including Q2 in Health Policy and both categories of Pharmacology—Pharmacoeconomics-Open engages with pressing issues in health economics, providing insights into cost-effectiveness analyses and healthcare decision-making. The journal’s commitment to high-quality, peer-reviewed articles ensures that it remains a significant player in advancing knowledge and understanding within its disciplines, serving as an essential forum for researchers, policymakers, and students alike.
International Journal of Health Economics and Management
Elevating healthcare management through rigorous economic research.International Journal of Health Economics and Management is a premier academic journal published by SPRINGER, focusing on innovative research at the intersection of health economics and management practices. Established in 2015, this journal caters to a diverse range of disciplines, integrating rigorous economic analysis with vital health policy discussions. With an impressive impact factor reflective of its influential publications, it holds a distinguished Q1 ranking in Economics, Econometrics, and Finance, and a Q2 ranking in Health Policy for 2023. The journal provides an open access model, enabling wider dissemination of research findings to academics, policymakers, and healthcare professionals globally. Researchers and students alike will find this journal invaluable for its commitment to advancing knowledge in health economics and improving healthcare management practices through empirical studies and theoretical insights. For more information, or to access articles, please refer to the journal's platform.